Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease

Abstract Introduction Severe COVID‐19 is associated with an important increase of von Willebrand factor and mild lowering of ADAMTS13 activity that may, in the presence of a strong inflammatory reaction, increase the risk of acute thrombotic thrombocytopenic purpura (TTP). Although acute episodes of...

Description complète

Détails bibliographiques

Auteurs principaux:	Erika Tarasco, Anne Sophie vonKrogh, Radomira Hrdlickova, Thomas R. Braschler, Teresa Iwaniec, Paul N. Knöbl, Eriko Hamada, Oleg Pikovsky, Stefan Farese, Odit Gutwein, Petr Kessler, Nina H. Schultz, Charis vonAuer, Jerzy Windyga, Kenneth Friedman, Ingrid Hrachovinova, James N. George, Masanori Matsumoto, Reinhard Schneppenheim, Bernhard Lämmle, Johanna Anna Kremer Hovinga
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2022-10-01
Collection:	Research and Practice in Thrombosis and Haemostasis
Sujets:	COVID‐19 congenital thrombotic thrombocytopenic purpura (cTTP) hereditary thrombotic thrombocytopenic purpura (hTTP) SARS‐CoV‐2 vaccines
Accès en ligne:	https://doi.org/10.1002/rth2.12814
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!